0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Biological Hemostatic Material - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-32M13746
Home | Market Reports | Health| Medical Devices & Equipment
Global Biological Hemostatic Material Market Research Report 2023
BUY CHAPTERS

Biological Hemostatic Material - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-32M13746
Report
September 2024
Pages:140
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biological Hemostatic Material - Market Size

The global market for Biological Hemostatic Material was estimated to be worth US$ 523 million in 2023 and is forecast to a readjusted size of US$ 798.6 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030

Biological Hemostatic Material - Market

Biological Hemostatic Material - Market

Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biological Hemostatic Material, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Biological Hemostatic Material by region & country, by Type, and by Application.
The Biological Hemostatic Material market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Hemostatic Material.
Market Segmentation

Scope of Biological Hemostatic Material - Market Report

Report Metric Details
Report Name Biological Hemostatic Material - Market
Forecasted market size in 2030 US$ 798.6 million
CAGR 6.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Collagen
  • Gelatin
  • Polysaccharides
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Biological Hemostatic Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Biological Hemostatic Material in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Biological Hemostatic Material in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Biological Hemostatic Material - Market size in 2030?

Ans: The Biological Hemostatic Material - Market size in 2030 will be US$ 798.6 million.

Who are the main players in the Biological Hemostatic Material - Market report?

Ans: The main players in the Biological Hemostatic Material - Market are Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products

What are the Application segmentation covered in the Biological Hemostatic Material - Market report?

Ans: The Applications covered in the Biological Hemostatic Material - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Biological Hemostatic Material - Market report?

Ans: The Types covered in the Biological Hemostatic Material - Market report are Collagen, Gelatin, Polysaccharides, Other

1 Market Overview
1.1 Biological Hemostatic Material Product Introduction
1.2 Global Biological Hemostatic Material Market Size Forecast
1.2.1 Global Biological Hemostatic Material Sales Value (2019-2030)
1.2.2 Global Biological Hemostatic Material Sales Volume (2019-2030)
1.2.3 Global Biological Hemostatic Material Sales Price (2019-2030)
1.3 Biological Hemostatic Material Market Trends & Drivers
1.3.1 Biological Hemostatic Material Industry Trends
1.3.2 Biological Hemostatic Material Market Drivers & Opportunity
1.3.3 Biological Hemostatic Material Market Challenges
1.3.4 Biological Hemostatic Material Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biological Hemostatic Material Players Revenue Ranking (2023)
2.2 Global Biological Hemostatic Material Revenue by Company (2019-2024)
2.3 Global Biological Hemostatic Material Players Sales Volume Ranking (2023)
2.4 Global Biological Hemostatic Material Sales Volume by Company Players (2019-2024)
2.5 Global Biological Hemostatic Material Average Price by Company (2019-2024)
2.6 Key Manufacturers Biological Hemostatic Material Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Biological Hemostatic Material Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Biological Hemostatic Material
2.9 Biological Hemostatic Material Market Competitive Analysis
2.9.1 Biological Hemostatic Material Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Biological Hemostatic Material Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Hemostatic Material as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Collagen
3.1.2 Gelatin
3.1.3 Polysaccharides
3.1.4 Other
3.2 Global Biological Hemostatic Material Sales Value by Type
3.2.1 Global Biological Hemostatic Material Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biological Hemostatic Material Sales Value, by Type (2019-2030)
3.2.3 Global Biological Hemostatic Material Sales Value, by Type (%) (2019-2030)
3.3 Global Biological Hemostatic Material Sales Volume by Type
3.3.1 Global Biological Hemostatic Material Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Biological Hemostatic Material Sales Volume, by Type (2019-2030)
3.3.3 Global Biological Hemostatic Material Sales Volume, by Type (%) (2019-2030)
3.4 Global Biological Hemostatic Material Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Biological Hemostatic Material Sales Value by Application
4.2.1 Global Biological Hemostatic Material Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biological Hemostatic Material Sales Value, by Application (2019-2030)
4.2.3 Global Biological Hemostatic Material Sales Value, by Application (%) (2019-2030)
4.3 Global Biological Hemostatic Material Sales Volume by Application
4.3.1 Global Biological Hemostatic Material Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Biological Hemostatic Material Sales Volume, by Application (2019-2030)
4.3.3 Global Biological Hemostatic Material Sales Volume, by Application (%) (2019-2030)
4.4 Global Biological Hemostatic Material Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Biological Hemostatic Material Sales Value by Region
5.1.1 Global Biological Hemostatic Material Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biological Hemostatic Material Sales Value by Region (2019-2024)
5.1.3 Global Biological Hemostatic Material Sales Value by Region (2025-2030)
5.1.4 Global Biological Hemostatic Material Sales Value by Region (%), (2019-2030)
5.2 Global Biological Hemostatic Material Sales Volume by Region
5.2.1 Global Biological Hemostatic Material Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Biological Hemostatic Material Sales Volume by Region (2019-2024)
5.2.3 Global Biological Hemostatic Material Sales Volume by Region (2025-2030)
5.2.4 Global Biological Hemostatic Material Sales Volume by Region (%), (2019-2030)
5.3 Global Biological Hemostatic Material Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Biological Hemostatic Material Sales Value, 2019-2030
5.4.2 North America Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Biological Hemostatic Material Sales Value, 2019-2030
5.5.2 Europe Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Biological Hemostatic Material Sales Value, 2019-2030
5.6.2 Asia Pacific Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Biological Hemostatic Material Sales Value, 2019-2030
5.7.2 South America Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Biological Hemostatic Material Sales Value, 2019-2030
5.8.2 Middle East & Africa Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biological Hemostatic Material Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biological Hemostatic Material Sales Value
6.2.1 Key Countries/Regions Biological Hemostatic Material Sales Value, 2019-2030
6.2.2 Key Countries/Regions Biological Hemostatic Material Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Biological Hemostatic Material Sales Value, 2019-2030
6.3.2 United States Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biological Hemostatic Material Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biological Hemostatic Material Sales Value, 2019-2030
6.4.2 Europe Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biological Hemostatic Material Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biological Hemostatic Material Sales Value, 2019-2030
6.5.2 China Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biological Hemostatic Material Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biological Hemostatic Material Sales Value, 2019-2030
6.6.2 Japan Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biological Hemostatic Material Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biological Hemostatic Material Sales Value, 2019-2030
6.7.2 South Korea Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biological Hemostatic Material Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biological Hemostatic Material Sales Value, 2019-2030
6.8.2 Southeast Asia Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biological Hemostatic Material Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biological Hemostatic Material Sales Value, 2019-2030
6.9.2 India Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biological Hemostatic Material Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Information
7.1.2 Johnson & Johnson Introduction and Business Overview
7.1.3 Johnson & Johnson Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Johnson & Johnson Biological Hemostatic Material Product Offerings
7.1.5 Johnson & Johnson Recent Development
7.2 BD
7.2.1 BD Company Information
7.2.2 BD Introduction and Business Overview
7.2.3 BD Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BD Biological Hemostatic Material Product Offerings
7.2.5 BD Recent Development
7.3 Baxter
7.3.1 Baxter Company Information
7.3.2 Baxter Introduction and Business Overview
7.3.3 Baxter Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Baxter Biological Hemostatic Material Product Offerings
7.3.5 Baxter Recent Development
7.4 B.Braun
7.4.1 B.Braun Company Information
7.4.2 B.Braun Introduction and Business Overview
7.4.3 B.Braun Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.4.4 B.Braun Biological Hemostatic Material Product Offerings
7.4.5 B.Braun Recent Development
7.5 Cura Medical
7.5.1 Cura Medical Company Information
7.5.2 Cura Medical Introduction and Business Overview
7.5.3 Cura Medical Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cura Medical Biological Hemostatic Material Product Offerings
7.5.5 Cura Medical Recent Development
7.6 GELITA MEDICAL
7.6.1 GELITA MEDICAL Company Information
7.6.2 GELITA MEDICAL Introduction and Business Overview
7.6.3 GELITA MEDICAL Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GELITA MEDICAL Biological Hemostatic Material Product Offerings
7.6.5 GELITA MEDICAL Recent Development
7.7 Curasan AG
7.7.1 Curasan AG Company Information
7.7.2 Curasan AG Introduction and Business Overview
7.7.3 Curasan AG Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Curasan AG Biological Hemostatic Material Product Offerings
7.7.5 Curasan AG Recent Development
7.8 Meril Life Sciences
7.8.1 Meril Life Sciences Company Information
7.8.2 Meril Life Sciences Introduction and Business Overview
7.8.3 Meril Life Sciences Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Meril Life Sciences Biological Hemostatic Material Product Offerings
7.8.5 Meril Life Sciences Recent Development
7.9 Zhonghui Shengxi
7.9.1 Zhonghui Shengxi Company Information
7.9.2 Zhonghui Shengxi Introduction and Business Overview
7.9.3 Zhonghui Shengxi Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Zhonghui Shengxi Biological Hemostatic Material Product Offerings
7.9.5 Zhonghui Shengxi Recent Development
7.10 Beijing Datsing Bio-tech
7.10.1 Beijing Datsing Bio-tech Company Information
7.10.2 Beijing Datsing Bio-tech Introduction and Business Overview
7.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Beijing Datsing Bio-tech Biological Hemostatic Material Product Offerings
7.10.5 Beijing Datsing Bio-tech Recent Development
7.11 Guizhou Jin Jiu Biotech
7.11.1 Guizhou Jin Jiu Biotech Company Information
7.11.2 Guizhou Jin Jiu Biotech Introduction and Business Overview
7.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Offerings
7.11.5 Guizhou Jin Jiu Biotech Recent Development
7.12 Beijing Taikesiman
7.12.1 Beijing Taikesiman Company Information
7.12.2 Beijing Taikesiman Introduction and Business Overview
7.12.3 Beijing Taikesiman Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Beijing Taikesiman Biological Hemostatic Material Product Offerings
7.12.5 Beijing Taikesiman Recent Development
7.13 Foryou Medical
7.13.1 Foryou Medical Company Information
7.13.2 Foryou Medical Introduction and Business Overview
7.13.3 Foryou Medical Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Foryou Medical Biological Hemostatic Material Product Offerings
7.13.5 Foryou Medical Recent Development
7.14 Saikesaisi Holdings Group
7.14.1 Saikesaisi Holdings Group Company Information
7.14.2 Saikesaisi Holdings Group Introduction and Business Overview
7.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Saikesaisi Holdings Group Biological Hemostatic Material Product Offerings
7.14.5 Saikesaisi Holdings Group Recent Development
7.15 Biotemed
7.15.1 Biotemed Company Information
7.15.2 Biotemed Introduction and Business Overview
7.15.3 Biotemed Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Biotemed Biological Hemostatic Material Product Offerings
7.15.5 Biotemed Recent Development
7.16 Hangzhou Singclean Medical Products
7.16.1 Hangzhou Singclean Medical Products Company Information
7.16.2 Hangzhou Singclean Medical Products Introduction and Business Overview
7.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Hangzhou Singclean Medical Products Biological Hemostatic Material Product Offerings
7.16.5 Hangzhou Singclean Medical Products Recent Development
8 Industry Chain Analysis
8.1 Biological Hemostatic Material Industrial Chain
8.2 Biological Hemostatic Material Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biological Hemostatic Material Sales Model
8.5.2 Sales Channel
8.5.3 Biological Hemostatic Material Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Biological Hemostatic Material Market Trends
    Table 2. Biological Hemostatic Material Market Drivers & Opportunity
    Table 3. Biological Hemostatic Material Market Challenges
    Table 4. Biological Hemostatic Material Market Restraints
    Table 5. Global Biological Hemostatic Material Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Biological Hemostatic Material Revenue Market Share by Company (2019-2024)
    Table 7. Global Biological Hemostatic Material Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Biological Hemostatic Material Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Biological Hemostatic Material Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Biological Hemostatic Material Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Biological Hemostatic Material Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Biological Hemostatic Material
    Table 13. Global Biological Hemostatic Material Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Hemostatic Material as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Biological Hemostatic Material Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Biological Hemostatic Material Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Biological Hemostatic Material Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Biological Hemostatic Material Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Biological Hemostatic Material Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Biological Hemostatic Material Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Biological Hemostatic Material Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Biological Hemostatic Material Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Biological Hemostatic Material Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Biological Hemostatic Material Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Biological Hemostatic Material Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Biological Hemostatic Material Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Biological Hemostatic Material Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Biological Hemostatic Material Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Biological Hemostatic Material Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Biological Hemostatic Material Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Biological Hemostatic Material Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Biological Hemostatic Material Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Biological Hemostatic Material Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Biological Hemostatic Material Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Biological Hemostatic Material Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Biological Hemostatic Material Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Biological Hemostatic Material Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Biological Hemostatic Material Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Biological Hemostatic Material Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Biological Hemostatic Material Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Biological Hemostatic Material Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Biological Hemostatic Material Sales Value by Region (2019-2024) & (%)
    Table 44. Global Biological Hemostatic Material Sales Value by Region (2025-2030) & (%)
    Table 45. Global Biological Hemostatic Material Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Biological Hemostatic Material Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Biological Hemostatic Material Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Biological Hemostatic Material Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Biological Hemostatic Material Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Biological Hemostatic Material Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Biological Hemostatic Material Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Biological Hemostatic Material Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Biological Hemostatic Material Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Biological Hemostatic Material Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Biological Hemostatic Material Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Biological Hemostatic Material Sales Volume, (2025-2030) & (K Units)
    Table 57. Johnson & Johnson Company Information
    Table 58. Johnson & Johnson Introduction and Business Overview
    Table 59. Johnson & Johnson Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Johnson & Johnson Biological Hemostatic Material Product Offerings
    Table 61. Johnson & Johnson Recent Development
    Table 62. BD Company Information
    Table 63. BD Introduction and Business Overview
    Table 64. BD Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. BD Biological Hemostatic Material Product Offerings
    Table 66. BD Recent Development
    Table 67. Baxter Company Information
    Table 68. Baxter Introduction and Business Overview
    Table 69. Baxter Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Baxter Biological Hemostatic Material Product Offerings
    Table 71. Baxter Recent Development
    Table 72. B.Braun Company Information
    Table 73. B.Braun Introduction and Business Overview
    Table 74. B.Braun Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. B.Braun Biological Hemostatic Material Product Offerings
    Table 76. B.Braun Recent Development
    Table 77. Cura Medical Company Information
    Table 78. Cura Medical Introduction and Business Overview
    Table 79. Cura Medical Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Cura Medical Biological Hemostatic Material Product Offerings
    Table 81. Cura Medical Recent Development
    Table 82. GELITA MEDICAL Company Information
    Table 83. GELITA MEDICAL Introduction and Business Overview
    Table 84. GELITA MEDICAL Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. GELITA MEDICAL Biological Hemostatic Material Product Offerings
    Table 86. GELITA MEDICAL Recent Development
    Table 87. Curasan AG Company Information
    Table 88. Curasan AG Introduction and Business Overview
    Table 89. Curasan AG Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Curasan AG Biological Hemostatic Material Product Offerings
    Table 91. Curasan AG Recent Development
    Table 92. Meril Life Sciences Company Information
    Table 93. Meril Life Sciences Introduction and Business Overview
    Table 94. Meril Life Sciences Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Meril Life Sciences Biological Hemostatic Material Product Offerings
    Table 96. Meril Life Sciences Recent Development
    Table 97. Zhonghui Shengxi Company Information
    Table 98. Zhonghui Shengxi Introduction and Business Overview
    Table 99. Zhonghui Shengxi Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Zhonghui Shengxi Biological Hemostatic Material Product Offerings
    Table 101. Zhonghui Shengxi Recent Development
    Table 102. Beijing Datsing Bio-tech Company Information
    Table 103. Beijing Datsing Bio-tech Introduction and Business Overview
    Table 104. Beijing Datsing Bio-tech Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Beijing Datsing Bio-tech Biological Hemostatic Material Product Offerings
    Table 106. Beijing Datsing Bio-tech Recent Development
    Table 107. Guizhou Jin Jiu Biotech Company Information
    Table 108. Guizhou Jin Jiu Biotech Introduction and Business Overview
    Table 109. Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Offerings
    Table 111. Guizhou Jin Jiu Biotech Recent Development
    Table 112. Beijing Taikesiman Company Information
    Table 113. Beijing Taikesiman Introduction and Business Overview
    Table 114. Beijing Taikesiman Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Beijing Taikesiman Biological Hemostatic Material Product Offerings
    Table 116. Beijing Taikesiman Recent Development
    Table 117. Foryou Medical Company Information
    Table 118. Foryou Medical Introduction and Business Overview
    Table 119. Foryou Medical Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Foryou Medical Biological Hemostatic Material Product Offerings
    Table 121. Foryou Medical Recent Development
    Table 122. Saikesaisi Holdings Group Company Information
    Table 123. Saikesaisi Holdings Group Introduction and Business Overview
    Table 124. Saikesaisi Holdings Group Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Saikesaisi Holdings Group Biological Hemostatic Material Product Offerings
    Table 126. Saikesaisi Holdings Group Recent Development
    Table 127. Biotemed Company Information
    Table 128. Biotemed Introduction and Business Overview
    Table 129. Biotemed Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Biotemed Biological Hemostatic Material Product Offerings
    Table 131. Biotemed Recent Development
    Table 132. Hangzhou Singclean Medical Products Company Information
    Table 133. Hangzhou Singclean Medical Products Introduction and Business Overview
    Table 134. Hangzhou Singclean Medical Products Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Hangzhou Singclean Medical Products Biological Hemostatic Material Product Offerings
    Table 136. Hangzhou Singclean Medical Products Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Biological Hemostatic Material Downstream Customers
    Table 140. Biological Hemostatic Material Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biological Hemostatic Material Product Picture
    Figure 2. Global Biological Hemostatic Material Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Biological Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Biological Hemostatic Material Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Biological Hemostatic Material Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Biological Hemostatic Material Report Years Considered
    Figure 7. Global Biological Hemostatic Material Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Biological Hemostatic Material Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Biological Hemostatic Material Revenue in 2023
    Figure 10. Biological Hemostatic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Collagen Picture
    Figure 12. Gelatin Picture
    Figure 13. Polysaccharides Picture
    Figure 14. Other Picture
    Figure 15. Global Biological Hemostatic Material Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Biological Hemostatic Material Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Biological Hemostatic Material Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Biological Hemostatic Material Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Biological Hemostatic Material Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Clinic
    Figure 22. Product Picture of Other
    Figure 23. Global Biological Hemostatic Material Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Biological Hemostatic Material Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Biological Hemostatic Material Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Biological Hemostatic Material Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Biological Hemostatic Material Price by Application (2019-2030) & (US$/Unit)
    Figure 28. North America Biological Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Biological Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Biological Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Biological Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Biological Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Biological Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Biological Hemostatic Material Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Biological Hemostatic Material Sales Volume (%), (2019-2030)
    Figure 40. United States Biological Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Biological Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Biological Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Biological Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Biological Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Biological Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Biological Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Biological Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Biological Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Biological Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Biological Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Biological Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Biological Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Biological Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Biological Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 61. Biological Hemostatic Material Industrial Chain
    Figure 62. Biological Hemostatic Material Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Electrosurgical Cutting Electrode Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-18M7037
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Treatment Trolleys Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-7B8751
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Monopolar Cutting Electrosurgical Unit Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-2L7328
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Cutting Electrosurgical Unit Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-35P6799
Sat Oct 12 00:00:00 UTC 2024

Add to Cart